POSC4 Modeling health-related outcomes with avelumab as a first-line maintenance treatment following chemotherapy vs. best supportive care (BSC) for patients with locally advanced or metastatic urothelial cancer in the UK

Critchlow, S., Xiao, Y., Crabb, S. et al. (9 more authors) (2022) POSC4 Modeling health-related outcomes with avelumab as a first-line maintenance treatment following chemotherapy vs. best supportive care (BSC) for patients with locally advanced or metastatic urothelial cancer in the UK. In: Value in Health. Virtual ISPOR Europe 2021, 30 Nov - 03 Dec 2021, Virtual conference. Elsevier BV , S32-S33.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2021 Published by Elsevier Inc.
Dates:
  • Published (online): 19 January 2022
  • Published: January 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 28 Mar 2022 13:11
Last Modified: 28 Mar 2022 13:11
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jval.2021.11.150

Share / Export

Statistics